Search

Objectives This study compared the scientific publication speeds of Korean medical journals before and during the coronavirus disease 2019 (COVID-19) era. Methods We analyzed 2,064 papers from 43 international Korean medical journals, selecting 12 papers annually from 2019 to 2022. We assessed publication speed indicators, including the time from submission to revision and from submission to publication. Additionally, we examined variations in publication speed based on journal and paper characteristics, including whether the studies were related to COVID-19. Results Among the 43 journals analyzed, 39.5% disclosed the peer review duration from submission to the first decision, and 11.6% reported their acceptance rates. The average time from submission to acceptance was 127.0 days in 2019, 126.1 days in 2020, 124.6 days in 2021, and 126.4 days in 2022. For COVID-19-related studies, the average time from submission to revision was 61.4 days, compared to 105.1 days for non-COVID-19 studies; from submission to acceptance, it was 87.4 days for COVID-19-related studies and 127.1 days for non-COVID-19 studies. All indicators for COVID-19-related studies showed shorter durations than those for non-COVID-19 studies, and the proportion of studies accepted within 30 or 60 days was significantly higher for COVID-19-related studies. Conclusions This study investigated the publication speed of Korean international medical journals before and during the COVID-19 pandemic. The pandemic influenced journals’ review and publication processes, potentially impacting the quality of academic papers. These findings provide insights into publication speeds during the COVID-19 era, suggesting that journals should focus on maintaining the integrity of their publication and review processes.

Purpose The multiyear COVID-19 pandemic has affected the volume and speed of publications in scientific journals. This study evaluated trends in the impact measures of international medical journals published in Korea, including the journal impact factor (JIF). Methods We selected Science Citation Index Expanded journals with the country/region set to Korea and the academic category classified as “clinical medicine” in Journal Citation Reports. Trends in indicators such as the JIF and Journal Citation Indicator (JCI) were assessed for journals with JIF information from 2018 to 2022. Ratios and differences between the measures were calculated to determine the extent of the change. Results We identified 43 journals, and the average JIF of those journals increased from 2.33 in 2018 and 2.50 in 2019 to 3.45 in 2020 and 3.86 in 2021. Other measures, such as the 5-year JIF and JCI, steadily increased, and the proportion of gold open access journals also increased significantly. However, the JCI and Eigenfactor scores remained steady or showed relatively small increases. Furthermore, impact measures declined in 2022, including a JIF decrease to 3.55. Conclusion We presented trends in quantitative measurements for international medical journals in Korea, and found an overall increase. Journals need to maintain a rigorous publication process to improve the quality of their research and the research community needs to exercise caution when using quantitative measures to evaluate journals. Further research is required to examine the quantitative indicators of journals, including their publication policies, research topics, and long-term trends.